Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-14-053511
Filing Date
2014-02-14
Accepted
2014-02-14 11:29:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-C d680013dsctoc.htm SC TO-C 22763
2 EX-99.1 d680013dex991.htm EX-99.1 16562
  Complete submission text file 0001193125-14-053511.txt   40863
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Subject) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-82506 | Film No.: 14612736
SIC: 2834 Pharmaceutical Preparations

Mailing Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filed by) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations